566 participants developed eGFR of 30mL/min/1 .73 m ( 2 ) , 244 developed eGFR of 15mL/min/1 .73 m ( 2 ) , and 437 , 336 , and 259 developed 1-year ESRD risks of 5 % , 10 % , and 20 % , respectively .